Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carmustine toxicity presenting as a lobar infiltrate

D L Patterson1, M C Wiemann, T H Lee

  • 1St. Vincent Hospital, Indianapolis.

Chest
|July 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimation of temperature and precipitation from morphological characters of dicotyledonous leaves.

American journal of botany·2011
Same author

Chemotherapy for ovarian cancer: an evidence-based approach.

Minerva ginecologica·2005
Same author

HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up.

European journal of gynaecological oncology·2004
Same author

Heat shock protein 27 in the placentas of women with and without severe preeclampsia.

Clinical and experimental obstetrics & gynecology·2004
Same author

Nuclear and cytoplasmic c-myc staining in endometrial carcinoma and their relationship to survival.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2004
Same author

Nuclear size, shape, and density in endometrial carcinoma: relationship to survival at over 5 years of follow-up. Does analyzing only cells occupying the G0-G1 peak add useful information?

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2004

Carmustine can cause lung damage (pulmonary fibrosis) in patients with brain tumors. This case report highlights an unusual lobar distribution of this serious chemotherapy side effect.

Area of Science:

  • Oncology
  • Pulmonology
  • Toxicology

Background:

  • Carmustine is a key chemotherapy drug for malignant brain tumors.
  • Pulmonary fibrosis is a known, significant side effect of carmustine treatment.
  • The incidence of carmustine-induced pulmonary fibrosis ranges from 20% to 30%.

Observation:

  • A patient undergoing carmustine therapy presented with pulmonary fibrosis.
  • The observed pulmonary fibrosis exhibited an atypical lobar pattern.
  • This presentation deviates from the typically diffuse or interstitial patterns reported.

Findings:

  • The case suggests carmustine as the likely cause of the observed pulmonary fibrosis.
  • The unusual lobar distribution represents a novel characteristic of this drug-induced lung injury.

Related Experiment Videos

  • Radiological and pathological findings are consistent with drug-induced lung disease.

    • Implications:

    • This case expands the understanding of carmustine's potential toxic effects on the lungs.
    • Awareness of unusual presentations is crucial for early diagnosis and management.
    • Further research may be needed to elucidate the mechanisms behind varied drug-induced lung injury patterns.